Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Shrinking team NBB
FTE fell two years in a row, from 11.4 to 9.7.
-
Busy address KBO
26 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
MBM PHARMA from Oudergem, company number BE0454016517, closed financial year 2025 with a result of € 354,875 after tax. For that financial year MBM PHARMA recorded a gross margin of € 1 million and equity of € 221,840. Compared with financial year 2024, the result moved from € 277,451 to € 354,875. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.
€ 221,840
▼ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 354,875
▲ 28% vs 2024
Profit after tax over the fiscal year.
€ 318,337
▼ 48% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 382,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
9.7
▼ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 579,952
▲ 4% vs 2024
€ 59,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 169,295
▲ 12% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 99,113
▲ 18% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 975,559 | € 991,951 | € 900,313 | € 1,013,684 | ▲ 13% |
| Profit after taxes | € 264,532 | € 317,306 | € 277,451 | € 354,875 | ▲ 28% |
| Equity | € 294,208 | € 267,514 | € 248,965 | € 221,840 | ▼ 11% |
| Total debts | € 349,501 | € 568,012 | € 530,679 | € 650,408 | ▲ 23% |
| Cash | € 359,755 | € 421,652 | € 614,088 | € 318,337 | ▼ 48% |
| Retained profit | € 203,257 | € 176,563 | € 158,014 | € 130,889 | ▼ 17% |
| Dividend | € 202,000 | € 344,000 | € 296,000 | € 382,000 | ▲ 29% |
| Bank debt | € 3,971 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 643,708 | € 835,526 | € 779,643 | € 872,248 | ▲ 12% |
| Employees (FTE) | 12.1 | 11.4 | 9.9 | 9.7 | ▼ 0.2 |
Key figures of MBM PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MBM PHARMA?
What happened at MBM PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 354,875 (▲ 28% vs 2024). Source: NBB ↗
- VV FINANCE SRL became a director. NBB
- New establishment in Namur. KBO
- MBM GROUPE SPRL became a director. NBB
- New establishment in Oudergem. KBO
- THIERRY GRAULICH became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 264,532 profit in 2022 to € 354,875 profit in 2025.
Paid € 278,577 in corporate taxes since 2022.
Best year ever: 2025, with € 354,875 profit.
On average € 104,500 of value added per employee in 2025.
A new publication or filing at MBM PHARMA? We notify you, reason included.
Follow MBM PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MBM Groupe comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
MBM PHARMABehind MBM PHARMA are THIERRY GRAULICH, VV FINANCE SRL and MBM GROUPE SPRL. The shares are held by MBM Groupe (100%).
Directors
According to the 2025 annual accounts
THIERRY GRAULICH
Director
Also active at: MBM Groupe, KUNZEA, MBM Medical, MASTERED BUSINESS MANAGEMENT & EDITION, MBM Cogeval, IMMO TEDESCO
since 2000
Director · represented by Jean-Philippe WYDOCK
Also active at: MBM Groupe, MBM Medical, MBM Cogeval
since 2024
Director · represented by CHRISTOPHE DEREUME
Also active at: MBM Medical, MBM Cogeval
since 2013
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Tedescolaan 7
1160 Oudergem
Tedescolaan 7 box 4
1160 Oudergem
Active since 1 January 2008
Chaussée de Liège(JB) 624
5100 Namur
Active since 3 December 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
All companies at this address →BV GROUP
€ 36,957 gross margin · 2025
BECOVA
€ -10,483 gross margin · 2025
Xirius Public
€ 131,503 gross margin · 2024
AMAND & CO
€ 34,452 gross margin · 2025
REVUE ADMINISTRATION PUBLIQUE
+21 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0454.016.517
- VAT number
- BE 0454.016.517
- Registered office
- Tedescolaan 7, 1160 Oudergem
- Names & denominations
- MBM PHARMA · M.B.M.
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 December 1994
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Boekhouders
Activiteiten van (gecertificeerde) (fiscaal) accountants
Boekhouders en boekhouders-fiscalisten
Belastingconsulenten
Accountants en belastingconsulenten